13F-HR filed by Matrix Capital Management Company, LP
Matrix Capital Management Company, LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 7 holding rows worth $2,094,563,353.
- Accession
- 0001172661-24-005158
- Filer
- CIK 1410830
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 7 entries on the cover page, a total value of $2,094,563,353 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,094,563,353 with VALUE read as dollars as filed, 13F file number 028-12595. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ALTAIR ENGINEERING INC | 021369103 | COMMON STOCK | 12,430,000 | $1,187,189,300 | dollars as filed | |
| GLOBALFOUNDRIES INC | G39387108 | ORDINARY SHARES | 16,514,952 | $664,726,818 | dollars as filed | |
| PERIMETER SOLUTIONS SA | L7579L106 | COMMON STOCK-FO | 6,725,000 | $90,451,250 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 6,922,870 | $61,682,772 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 13,959,973 | $51,372,701 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 37,681,515 | $35,812,512 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 650,000 | $3,328,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-24-005158 | this filing | 2024-11-14 | acceptance time not in the bulk data set |